Hoffman Beth J. 4

What Happened

Beth J. Hoffman, a director of Biofrontera Inc. (BFRI), was granted a derivative award of 20,000 shares on March 4, 2026. The grant is reported with an acquisition price of $0.00 (total reported value $0) and is recorded on the Form 4 as a grant/award (derivative security), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-03-04; Form 4 filed: 2026-03-06 (timely filing).
• Award: 20,000 derivative shares reported at $0.00 acquisition price (total $0).
• Vesting: Footnote F1 — vests in twelve equal monthly installments beginning April 4, 2026.
• Footnote F2: Options with different terms are not included in this reporting.
• Shares owned after the transaction: not specified in the disclosed transaction details.
• Transaction code: A = Grant/Award (derivative).

Context

This was a compensation-related grant (derivative award) rather than a market purchase or sale. The award will vest monthly over one year; there is no indication of immediate sale or cashless exercise in the filing. Grants like this typically reflect compensation practices and should not be read as a direct buy/sell signal.